Related Experiment Video
Updated: Jun 21, 2026

Isolation, Expansion, and Adipogenic Induction of CD34+CD31+ Endothelial Cells from Human Omental and Subcutaneous Adipose Tissue
Published on: July 17, 2018
Adiponectin in children on peritoneal dialysis: relationship to insulin resistance and nutritional status
Mariana Kamariski1, Mónica Biscardi, Laura Cestino
1Area de Fisiopatología, Departamento de Patología, Facultad de Ciencias Médicas, Universidad Nacional de Cuyo, Mendoza, Argentina.
Insights
In pediatric peritoneal dialysis (PD) patients, higher adiponectin levels correlate with lower body mass index (BMI) and body fat, suggesting a role in clinical wasting. Resistin levels did not differ significantly among groups.
Area of Science:
- Pediatric Nephrology
- Endocrinology
- Nutritional Science
Background:
- Peritoneal dialysis (PD) in children can impact nutritional status and metabolic health.
- Adiponectin and resistin are adipokines with known roles in metabolism and inflammation, but their specific associations in pediatric PD patients are not well-defined.
Purpose of the Study:
- To investigate the relationship between serum adiponectin and resistin levels and insulin resistance (IR) and anthropometric parameters in children undergoing PD.
- To compare these parameters between PD patients, chronic kidney disease (CKD) patients, and healthy controls.
Main Methods:
- Oral glucose tolerance test to measure glucose and insulin.
- Enzyme-linked immunosorbent assay (ELISA) for adiponectin and resistin.
- Radioimmunoassay (RIA) for insulin.
Main Results:
- PD patients exhibited significantly higher adiponectin levels and lower body mass index (BMI) and body fat content compared to controls.
- CKD patients showed higher insulin resistance (IR) markers (HOMA-IR, fasting and 2-hour insulin) than controls and PD patients.
- Adiponectin was inversely associated with BMI, weight, height z-score, and body fat, but not directly with IR parameters. Both adiponectin and resistin correlated negatively with glomerular filtration rate.
Conclusions:
- Adiponectin may play a role in the clinical wasting observed in pediatric PD patients, as indicated by its association with reduced anthropometric parameters.
- Further research is warranted to elucidate the precise mechanisms linking adiponectin to nutritional status in this population.
Aim:
To study whether adiponectin and resistin serum concentrations in children on peritoneal dialysis (PD) were related to insulin resistance (IR) and anthropometric parameters of nutritional status, 11 PD patients, 9 chronic kidney disease (CKD) patients and 10 healthy children were studied.
Methods:
Glucose and insulin were measured during the oral glucose tolerance test. Levels of adiponectin and resistin were evaluated by ELISA, insulin by RIA.
Results:
In CKD patients, higher homeostasis model assessment-insulin resistance (HOMA-IR), fasting and 2-hour serum insulin levels were shown compared to control and to PD patients. Body mass index (BMI) and body fat content were severely decreased while serum adiponectin levels were significantly higher in PD patients relative to controls. No differences among groups were shown in resistin levels. On regression modeling, inverse independent associations were observed between adiponectin with percentile BMI, weight and height z-score, and with body fat content. In contrast, no relationship was found between adiponectin and IR parameters. In multiple regression analysis, adiponectin was negatively correlated with BMI. A negative association of adiponectin and resistin with glomerular filtration rate was also shown.
Conclusion:
A role for adiponectin in terms of its association with clinical wasting parameters in PD pediatric patients might be suggested.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Peritoneal Dialysis III: Nursing Management
Diabetic Nephropathy
Type II Diabetes II: Pathophysiology
Insulin: The Receptor and Signaling Pathways
